×
Visit The Official Physician Site To View Clinical Study Data For LYNPARZA. Learn About A...
Learn More About ZEJULA Clinical Trials. Visit Official Patient Site For More Information. Find Clinical Trial , Important Safety, & Dosing Information On Official Patient Site.

Niraparib

Medication
Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is taken by mouth. It is a PARP inhibitor. Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L01XK02 (WHO)
Elimination half-life: 36 hours
Metabolites: M1 (carboxylic acid)
Other names: MK-4827